Contrary to lackluster short-term results, elective intra-aortic balloon pump (IABP) therapy in high-risk patients receiving percutaneous coronary intervention (PCI) substantially reduces all-cause ...
Announcing a new article publication for Cardiovascular Innovations and Applications journal. An intra-aortic balloon pump (IABP) is the device most frequently used as a bridge to surgical repair in ...
In a cohort of patients who underwent high-risk PCI, mechanical circulatory support with a microaxial blood pump was linked to lower odds of death, MI and cardiogenic shock compared with use of an ...
WAYNE, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced FDA 510(k) clearance of the AC3 Range™ Intra-Aortic ...
PARIS -- Intra-aortic balloon pumps (IABP) didn't significantly improve outcomes for patients with ischemia persisting well after percutaneous coronary intervention (PCI) for a large acute ST-segment ...
The US Food and Drug Administration (FDA) today issued a letter to healthcare providers describing a current shortage of Getinge intra-aortic balloon pump (IABP) catheters and other components.
Maquet/Datascope intra-aortic balloon pumps (IABPs) may be at risk of shutting down while running on batteries, failure of their batteries to charge, or premature battery depletion, the US Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback